Transforming growth factor-β1 induces Smad3-dependent β1 integrin gene expression in epithelial-to-mesenchymal transition during chronic tubulointerstitial fibrosis

研究成果: Article

82 引文 (Scopus)

摘要

Transforming growth factor-β1 (TGF-β1)-induced epithelial-to-mesenchymal transition (EMT) contributes to the pathophysiological development of kidney fibrosis. Although it was reported that TGF-β1 enhances β1 integrin levels in NMuMG cells, the detailed molecular mechanisms underlying TGF-β1-induced β1 integrin gene expression and the role of β1 integrin during EMT in the renal system are still unclear. In this study, we examined the role of β1 integrin in TGF-β1-induced EMT both in vitro and in vivo. TGF-β1-induced augmentation of β1 integrin expression was required for EMT in several epithelial cell lines, and knockdown of Smad3 inhibited TGF-β1-induced augmentation of β1 integrin. TGF-β1 triggered β1 integrin gene promoter activity as assessed by luciferase activity assay. Both knockdown of Smad3 and mutation of the Smad-binding element to block binding to the β1 integrin promoter markedly reduced TGF-β1-induced β1 integrin promoter activity. Chromatin immunoprecipitation assay showed that TGF-β1 enhanced Smad3 binding to the β1 integrin promoter. Furthermore, induction of unilateral ureteral obstruction triggered increases of β1 integrin in both renal epithelial and interstitial cells. In human kidney with chronic tubulointerstitial fibrosis, we also found a concomitant increase of β1 integrin and α-smooth muscle actin in tubule epithelia. Blockade of β1 integrin signaling dampened the progression of fibrosis. Taken together, β1 integrin mediates EMT and subsequent tubulointerstitutial fibrosis, suggesting that inhibition of β1 integrin is a possible therapeutic target for prevention of renal fibrosis.

原文English
頁(從 - 到)1743-1754
頁數12
期刊American Journal of Pathology
177
發行號4
DOIs
出版狀態Published - 2010 十月

指紋

Epithelial-Mesenchymal Transition
Transforming Growth Factors
Integrins
Fibrosis
Gene Expression
Kidney
Epithelial Cells
Ureteral Obstruction
Chromatin Immunoprecipitation
Luciferases

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine

引用此文

@article{7abf5140180043bc923b1bf7dfb3e7d6,
title = "Transforming growth factor-β1 induces Smad3-dependent β1 integrin gene expression in epithelial-to-mesenchymal transition during chronic tubulointerstitial fibrosis",
abstract = "Transforming growth factor-β1 (TGF-β1)-induced epithelial-to-mesenchymal transition (EMT) contributes to the pathophysiological development of kidney fibrosis. Although it was reported that TGF-β1 enhances β1 integrin levels in NMuMG cells, the detailed molecular mechanisms underlying TGF-β1-induced β1 integrin gene expression and the role of β1 integrin during EMT in the renal system are still unclear. In this study, we examined the role of β1 integrin in TGF-β1-induced EMT both in vitro and in vivo. TGF-β1-induced augmentation of β1 integrin expression was required for EMT in several epithelial cell lines, and knockdown of Smad3 inhibited TGF-β1-induced augmentation of β1 integrin. TGF-β1 triggered β1 integrin gene promoter activity as assessed by luciferase activity assay. Both knockdown of Smad3 and mutation of the Smad-binding element to block binding to the β1 integrin promoter markedly reduced TGF-β1-induced β1 integrin promoter activity. Chromatin immunoprecipitation assay showed that TGF-β1 enhanced Smad3 binding to the β1 integrin promoter. Furthermore, induction of unilateral ureteral obstruction triggered increases of β1 integrin in both renal epithelial and interstitial cells. In human kidney with chronic tubulointerstitial fibrosis, we also found a concomitant increase of β1 integrin and α-smooth muscle actin in tubule epithelia. Blockade of β1 integrin signaling dampened the progression of fibrosis. Taken together, β1 integrin mediates EMT and subsequent tubulointerstitutial fibrosis, suggesting that inhibition of β1 integrin is a possible therapeutic target for prevention of renal fibrosis.",
author = "Yeh, {Yi Chun} and Wei, {Wei Chun} and Wang, {Yang Kao} and Lin, {Shih Chieh} and Sung, {Junne Ming} and Tang, {Ming Jer}",
year = "2010",
month = "10",
doi = "10.2353/ajpath.2010.091183",
language = "English",
volume = "177",
pages = "1743--1754",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Transforming growth factor-β1 induces Smad3-dependent β1 integrin gene expression in epithelial-to-mesenchymal transition during chronic tubulointerstitial fibrosis

AU - Yeh, Yi Chun

AU - Wei, Wei Chun

AU - Wang, Yang Kao

AU - Lin, Shih Chieh

AU - Sung, Junne Ming

AU - Tang, Ming Jer

PY - 2010/10

Y1 - 2010/10

N2 - Transforming growth factor-β1 (TGF-β1)-induced epithelial-to-mesenchymal transition (EMT) contributes to the pathophysiological development of kidney fibrosis. Although it was reported that TGF-β1 enhances β1 integrin levels in NMuMG cells, the detailed molecular mechanisms underlying TGF-β1-induced β1 integrin gene expression and the role of β1 integrin during EMT in the renal system are still unclear. In this study, we examined the role of β1 integrin in TGF-β1-induced EMT both in vitro and in vivo. TGF-β1-induced augmentation of β1 integrin expression was required for EMT in several epithelial cell lines, and knockdown of Smad3 inhibited TGF-β1-induced augmentation of β1 integrin. TGF-β1 triggered β1 integrin gene promoter activity as assessed by luciferase activity assay. Both knockdown of Smad3 and mutation of the Smad-binding element to block binding to the β1 integrin promoter markedly reduced TGF-β1-induced β1 integrin promoter activity. Chromatin immunoprecipitation assay showed that TGF-β1 enhanced Smad3 binding to the β1 integrin promoter. Furthermore, induction of unilateral ureteral obstruction triggered increases of β1 integrin in both renal epithelial and interstitial cells. In human kidney with chronic tubulointerstitial fibrosis, we also found a concomitant increase of β1 integrin and α-smooth muscle actin in tubule epithelia. Blockade of β1 integrin signaling dampened the progression of fibrosis. Taken together, β1 integrin mediates EMT and subsequent tubulointerstitutial fibrosis, suggesting that inhibition of β1 integrin is a possible therapeutic target for prevention of renal fibrosis.

AB - Transforming growth factor-β1 (TGF-β1)-induced epithelial-to-mesenchymal transition (EMT) contributes to the pathophysiological development of kidney fibrosis. Although it was reported that TGF-β1 enhances β1 integrin levels in NMuMG cells, the detailed molecular mechanisms underlying TGF-β1-induced β1 integrin gene expression and the role of β1 integrin during EMT in the renal system are still unclear. In this study, we examined the role of β1 integrin in TGF-β1-induced EMT both in vitro and in vivo. TGF-β1-induced augmentation of β1 integrin expression was required for EMT in several epithelial cell lines, and knockdown of Smad3 inhibited TGF-β1-induced augmentation of β1 integrin. TGF-β1 triggered β1 integrin gene promoter activity as assessed by luciferase activity assay. Both knockdown of Smad3 and mutation of the Smad-binding element to block binding to the β1 integrin promoter markedly reduced TGF-β1-induced β1 integrin promoter activity. Chromatin immunoprecipitation assay showed that TGF-β1 enhanced Smad3 binding to the β1 integrin promoter. Furthermore, induction of unilateral ureteral obstruction triggered increases of β1 integrin in both renal epithelial and interstitial cells. In human kidney with chronic tubulointerstitial fibrosis, we also found a concomitant increase of β1 integrin and α-smooth muscle actin in tubule epithelia. Blockade of β1 integrin signaling dampened the progression of fibrosis. Taken together, β1 integrin mediates EMT and subsequent tubulointerstitutial fibrosis, suggesting that inhibition of β1 integrin is a possible therapeutic target for prevention of renal fibrosis.

UR - http://www.scopus.com/inward/record.url?scp=77957334362&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957334362&partnerID=8YFLogxK

U2 - 10.2353/ajpath.2010.091183

DO - 10.2353/ajpath.2010.091183

M3 - Article

C2 - 20709799

AN - SCOPUS:77957334362

VL - 177

SP - 1743

EP - 1754

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 4

ER -